Stimulated protein degradation to promote mitochondrial function and neuronal survival
Science · 29.10.2026 · 394 (6823)
DOI: 10.1126/science.aed2525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 29.10.2026. Verfasst von Srividya Chandrasekhar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, USA. Hauptthemen laut MEDLINE: Cullin Proteins, Mitochondria, Neurons, Proteolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: National Institutes of Health, Howard Hughes Medical Institute, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Targeted protein degradation is a promising modality to treat cancer or inflammation, but whether it can provide a similar benefit for disorders caused by pervasive protein dysregulation is unclear. We describe stimulated protein degradation (SPD) as a strategy that leverages agonists of stress-responsive E3 ubiquitin ligases to simultaneously eliminate multiple pathogenic factors. Specifically, we show that activators of the reductive stress response E3 CUL2 FEM1B boost degradation of multiple physiological substrates to improve mitochondrial import and electron transport chain assembly. In this manner, CUL2 FEM1B agonists preserve mitochondrial function and neuronal survival in models of neurodegenerative COX deficiency syndrome and Friedreich’s ataxia. By activating E3 ligases that evolved to safeguard cellular integrity, SPD expands the use of compound-induced protein degradation to complex pathologies of high unmet need.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, USA.
- Howard Hughes Medical Institute, University of California at Berkeley, Berkeley, CA, USA.
- California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, USA.
- Molecular Therapeutics Initiative, University of California at Berkeley, Berkeley, CA, USA.
- Genentech Inc. South San Francisco, CA, USA.
ORCID-Profile: Srividya Chandrasekhar, Rachael McMinimy, Andrew G Manford, Eddie Wehri, Christine L Gee, Baris Bingol, John Kuriyan, Julia Schaletzky, Michael Rapé
Förderung
- National Institutes of Health
- Howard Hughes Medical Institute
- National Institute of General Medical Sciences
- Department of Energy
Zitieren
APA
Chandrasekhar, S., McMinimy, R., Manford, A. G., Wehri, E., Gee, C. L., Miller, C., Bingol, B., Kuriyan, J., Schaletzky, J., & Rapé, M. (2026). Stimulated protein degradation to promote mitochondrial function and neuronal survival. Science, 394(6823). https://doi.org/10.1126/science.aed2525
Vancouver
Chandrasekhar S, McMinimy R, Manford AG, Wehri E, Gee CL, Miller C, et al. Stimulated protein degradation to promote mitochondrial function and neuronal survival. Science. 2026;394(6823). doi:10.1126/science.aed2525
BibTeX
@article{Chandrasekhar2026,
author = {Chandrasekhar, Srividya and McMinimy, Rachael and Manford, Andrew G and Wehri, Eddie and Gee, Christine L and Miller, Caitlyn and Bingol, Baris and Kuriyan, John and Schaletzky, Julia and Rapé, Michael},
title = {Stimulated protein degradation to promote mitochondrial function and neuronal survival},
journal = {Science},
year = {2026},
volume = {394},
number = {6823},
doi = {10.1126/science.aed2525}
}
EUVIMED